These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10191752)

  • 1. Alendronate did not inhibit instability-induced bone resorption. A study in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 1999 Feb; 70(1):67-70. PubMed ID: 10191752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rat model for testing pharmacologic treatments of pressure-related bone loss.
    Astrand J; Skripitz R; Skoglund B; Aspenberg P
    Clin Orthop Relat Res; 2003 Apr; (409):296-305. PubMed ID: 12671515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alendronate on particle-induced osteolysis in a rat model.
    Millett PJ; Allen MJ; Bostrom MP
    J Bone Joint Surg Am; 2002 Feb; 84(2):236-49. PubMed ID: 11861730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening.
    Aspenberg P; Agholme F; Magnusson P; Fahlgren A
    Bone; 2011 Feb; 48(2):225-30. PubMed ID: 20858557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprosthetic bone resorption. Particles versus movement.
    Aspenberg P; Herbertsson P
    J Bone Joint Surg Br; 1996 Jul; 78(4):641-6. PubMed ID: 8682835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.
    Astrand J; Aspenberg P
    J Orthop Res; 2004 Mar; 22(2):244-9. PubMed ID: 15013081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic alendronate treatment improves fixation of press-fit implants: a canine study using nonloaded implants.
    Jensen TB; Bechtold JE; Chen X; Søballe K
    J Orthop Res; 2007 Jun; 25(6):772-8. PubMed ID: 17318896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.
    Siebelt M; Waarsing JH; Groen HC; Müller C; Koelewijn SJ; de Blois E; Verhaar JA; de Jong M; Weinans H
    Bone; 2014 Sep; 66():163-70. PubMed ID: 24933343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients.
    Jaroma AV; Soininvaara TA; Kröger H
    Bone Joint J; 2015 Mar; 97-B(3):337-45. PubMed ID: 25737517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate inhibits bone resorption at the bone-screw interface.
    Miyaji T; Nakase T; Azuma Y; Shimizu N; Uchiyama Y; Yoshikawa H
    Clin Orthop Relat Res; 2005 Jan; (430):195-201. PubMed ID: 15662324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model.
    Shanbhag AS; Hasselman CT; Rubash HE
    Clin Orthop Relat Res; 1997 Nov; (344):33-43. PubMed ID: 9372756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients.
    Soininvaara TA; Jurvelin JS; Miettinen HJ; Suomalainen OT; Alhava EM; Kröger PJ
    Calcif Tissue Int; 2002 Dec; 71(6):472-7. PubMed ID: 12370800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure-induced periprosthetic osteolysis: a rat model.
    Skripitz R; Aspenberg P
    J Orthop Res; 2000 May; 18(3):481-4. PubMed ID: 10937637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of particulate debris-induced osteolysis by alendronate in a rat model.
    Thadani PJ; Waxman B; Sladek E; Barmada R; Gonzalez MH
    Orthopedics; 2002 Jan; 25(1):59-63. PubMed ID: 11811243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of alendronate administration on bone mineral density and bone strength in castrated rats.
    Broulik PD; Rosenkrancová J; Růzicka P; Sedlácek R
    Horm Metab Res; 2005 Jul; 37(7):414-8. PubMed ID: 16034712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study.
    Venesmaa PK; Kröger HP; Miettinen HJ; Jurvelin JS; Suomalainen OT; Alhav EM
    J Bone Miner Res; 2001 Nov; 16(11):2126-31. PubMed ID: 11697810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effects of bisphosphonates on the biomechanical properties of canine bone.
    Wang X; Shanbhag AS; Rubash HE; Agrawal CM
    J Biomed Mater Res; 1999 Mar; 44(4):456-60. PubMed ID: 10397950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible.
    Kaynak D; Meffert R; Bostanci H; Günhan O; Ozkaya OG
    J Periodontol; 2003 Sep; 74(9):1348-54. PubMed ID: 14584869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine model of prosthesis failure for the long-term study of aseptic loosening.
    Yang SY; Yu H; Gong W; Wu B; Mayton L; Costello R; Wooley PH
    J Orthop Res; 2007 May; 25(5):603-11. PubMed ID: 17278141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.